Related Experiment Video
Updated: Jul 18, 2026
09:39
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Mouse tumor model for neurofibromatosis type 1
K S Vogel1, L J Klesse, S Velasco-Miguel
1Center for Developmental Biology and Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, TX 75235-9133, USA.
Science (New York, N.Y.)
|December 11, 1999
Summary
Neurofibromatosis type 1 (NF1) and p53 gene mutations accelerate tumor development. Mice lacking both Nf1 and p53 genes rapidly develop malignant neural crest tumors, offering insights into NF1 cancer risks.
Area of Science:
- Oncology
- Genetics
- Developmental Biology
Background:
- Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder linked to neural crest tumors.
- Activating ras protooncogene mutations and p53 tumor suppressor gene inactivation are implicated in malignant transformation.
Purpose of the Study:
- To investigate the synergistic effect of Nf1 and p53 gene mutations on tumor development.
- To characterize the resulting tumors in a preclinical model.
Main Methods:
- Generation of mice with combined null alleles for Nf1 and p53.
- Monitoring tumor incidence and age of onset.
- Analysis of tumor characteristics, including loss of heterozygosity and phenotypic traits.
Main Results:
- 100% of mice with cis-acting null Nf1 and p53 alleles developed soft tissue sarcomas between 3-7 months of age.
- These sarcomas showed loss of heterozygosity at both Nf1 and p53 loci.
- Tumors exhibited phenotypic traits of neural crest derivatives and human NF1 malignancies.
Conclusions:
- Loss of Nf1 and p53 function cooperatively drives malignant transformation in neural crest cells.
- This mouse model accurately recapitulates key features of NF1-associated malignancies.
- Understanding these genetic interactions is crucial for developing targeted therapies for NF1.
